Related Experiment Video
Updated: Feb 11, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Good Outcomes with the Intraventricular Vancomycin Therapy in a Patient with Ruptured Brain Abscesses
Ninh Doan1, Ha Nguyen1, Li Luyuan2
1Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, USA.
Abstract:
Brain abscesses are associated with high morbidity and mortality rates. In particular, patients with intraventricular rupture of brain abscess (IVROBA) exhibit mortality rates up to 85%. Treatment options are lacking for IVROBA, once patients become refractory to intravenous antibiotics and surgical drainage. Limited data exist regarding the risks and benefits of intraventricular therapy in such a scenario. We report a patient with IVROBA, who deteriorated while on systemic antibiotics; once intraventricular vancomycin was employed, the patient demonstrated remarkable improvement without perceivable side effects. This case suggests that intraventricular vancomycin may be a safe, effective, and viable option for the treatment of IVROBA, especially for patients becoming refractory to systemic antibiotics.
Insights
Intraventricular vancomycin offers a promising treatment for brain abscesses that rupture into the ventricles (IVROBA). This approach showed significant improvement in a patient refractory to standard antibiotic therapy.
Area of Science:
- Neurology
- Infectious Diseases
- Neurosurgery
Background:
- Brain abscesses carry high morbidity and mortality.
- Intraventricular rupture of brain abscess (IVROBA) has a particularly grim prognosis, with mortality rates up to 85%.
- Effective treatment options for IVROBA refractory to intravenous antibiotics and surgical drainage are limited.
Observation:
- A patient with IVROBA deteriorated despite systemic antibiotic treatment.
- Intraventricular vancomycin therapy was initiated in this refractory case.
Findings:
- The patient demonstrated remarkable clinical improvement following intraventricular vancomycin administration.
- No discernible side effects were observed during the intraventricular vancomycin treatment.
Implications:
- Intraventricular vancomycin may represent a safe and effective therapeutic option for IVROBA.
- This approach could be particularly valuable for patients with IVROBA who do not respond to conventional systemic treatments.
Related Concept Videos
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Gene Therapy
Group Therapy
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...

